Copenhagen, March 12, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that the Company will be hosting an investor call at which Chief Executive Officer, Anders Hinsby, and Chief Financial Officer, Anders Vadsholt, will be presenting the Orphazyme Annual Report 2017. The presentation will be followed by a Q&A session.

The call will be held on: Thursday, March 15, 2018 at 11.00 AM CET.

Dial-in details:

  • Denmark: +45 35 15 80 49

  • United Kingdom: +44 (0)330 336 9105

  • United States: +1 646 828 8156

Event Title: Orphazyme Annual Report 2017

Confirmation code: 7829588

The presentation will also be available via webcast: https://edge.media-server.com/m6/p/gdifg3gn

After the call, the presentation will be available via the above link or by using the following dial-in details.